Product correctly added to cart.

discount label
ER 819762
View 3D

Biosynth logo

ER 819762

CAS: 1155773-15-1

Ref. 3D-FWB77315

25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 26 Nov 2024

Product Information

Name:
ER 819762
Description:

ER 819762 is a potent anticancer drug that targets the cell cycle and induces apoptosis in human cancer cells. It is a kinase inhibitor that has been shown to be effective against a variety of cancers, including leukemia. ER 819762 works by blocking the activity of specific proteins involved in cell growth and division, which ultimately leads to cell death. This drug has been isolated from Chinese medicinal plants and shows promising potential as a new treatment for cancer. In addition to its anticancer properties, ER 819762 may also have other therapeutic applications due to its ability to inhibit protein function. Overall, ER 819762 is an exciting new development in cancer research with the potential to revolutionize cancer treatment.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
489.6 g/mol
Formula:
C30H39N3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FWB77315 ER 819762

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".